Skip to main content
. 2022 Oct 25;20:487. doi: 10.1186/s12967-022-03662-7

Fig. 1.

Fig. 1

DNA methylation for each CpG at promoter MB-COMT(c) and S-COMT in healthy controls (HC) and patients with Chronic Fatigue Syndrome and Fibromyalgia (CFS/FM), at both assessments. Statistically significant difference for mean methylation were found only at the MB-COMT promoter. Error bars represent 95% confidence interval.